COMP <GO>
DEC vs TMO // EV/EBITDA & P/E VALUATION
Diversified Energy Company (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: DEC 7
— TMO 4
▲ EV/EBITDA & P/E VALUATION LEADER: DEC
LAST: $14.61 (-0.41%) • MKT CAP: $1.12B
valuation
5.5x
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
valuation
30.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DEC VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | DEC | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.50% | 9.30% | +2.20 | DEC | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 5.5x | 30.4x | -24.90 | DEC | /valuation <GO> |
| Free Cash Flow Yield | 24.97% | 2.40% | +22.57 | DEC | /fcf-yield <GO> |
| Operating Margin | 29.20% | 17.40% | +11.80 | DEC | /operating-margins <GO> |
| Net Profit Margin | 18.60% | 15.10% | +3.50 | DEC | /net-margins <GO> |
| Revenue Growth (YoY) | 141.50% | 3.90% | +137.60 | DEC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 7.58% | 0.24% | +7.34 | DEC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.51 | 4.50 | -3.99 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.4 | 62.9 | -11.48 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 36.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.12B | $262.22B | -$261.10B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | DEC REV | TMO REV | DEC GROSS % | TMO GROSS % | DEC FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.83B | $44.56B | — | — | $280.0M | $6.29B |
| FY 2024 | $757.3M | $42.88B | — | — | $168.6M | $7.27B |
| FY 2023 | $1.95B | $42.86B | — | — | $291.4M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DEC // BETA —
TMO // BETA 0.94